The 'staggering' cost of pharmacy drugs is driving most of the increase, says Ellen Kelsay of the Business Group on Health, which released new data this week.
A handful of these voluntary benefits are perennial favorites with employers, while others, like identity theft protection plans, are gaining steam among offerings.
The FDA's decision on Aug. 9, 2024, not to approve MDMA to treat PTSD marks a blow to a small but growing number of employers offering healthcare coverage for psychedelic drugs to treat mental health issues like depression.
Awareness and access remain obstacles preventing lower-income workers from taking advantage of employee wellbeing benefits. Experts share what HR can do.
While embracing flexibility enhances agility, reduces costs and broadens the talent pool, it also requires thoughtful planning, a robust tech stack and a commitment to an inclusive and adaptive workplace culture.
As screening practices evolve and employees look for cost savings, employers will see more requests for enhanced breast cancer screening benefits, these experts write.
